Overview

Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
A phase 3 study to evaluate efficacy and safety of Co-administered HGP0904, HGP0608 and HGP0816 in Patients with Hypertension and Dyslipidemia
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited